Athlete with a stubborn tendon: PRP, cells, and the season clock
This is a composite decision situation, not a real patient, testimonial or individual treatment recommendation.
The Achilles or patellar tendon has eaten a season. Load management, eccentric protocols, shockwave — done, twice. A teammate swears by PRP; a clinic upsells “stem cells” at five times the price; the sports-med calendar pressure says decide now.
What the data says for this situation
Tendinopathy evidence favours patience over injections: eccentric/heavy-slow-resistance loading remains the backbone with the strongest outcomes. PRP's large trial base (drawn from the same ~1,800-paper knee/tendon literature) is genuinely mixed for tendons — some positives in patellar tendinopathy, notable nulls in Achilles. True cell injections for tendons ride mostly on small series and the rodent-heavy healing literature; controlled human superiority over PRP or loading has not been shown. For a competing athlete, WADA adds a layer: PRP is permitted, many peptides and growth-factor products are not.
Questions worth asking any provider
- Has my loading programme actually been exhausted (months, supervised, progressive)?
- If injecting: what exactly — PRP formulation, or a cell product with what evidence?
- WADA status of everything proposed?
- Return-to-play criteria: measured how?
Red flags specific to this situation
- “Stem cell” tendon offers priced far above PRP with no comparative data
- Injection-first plans skipping loading rehab
- Peptide add-ons (BPC-157 et al.) offered to tested athletes
Cost context
PRP tendon courses: €300–€900 per injection in Europe. Cell offers commonly run €3,000–€8,000 without evidence of superiority. Supervised loading programmes outperform both in trials.
FAQ
PRP or stem cells for tendinopathy?
Neither beats structured loading in trials; if injecting, PRP has far more human data at a fraction of the price.
Is PRP allowed in competition?
Yes under WADA rules; many peptide 'healing' add-ons are not.
→ Build questions for a specific provider · → Cost calculator
Interactive/editorial page by the StemCellAtlas research team. Where registry or literature counts appear, they use the dated 2026-08-29 snapshot. Browser-only tools do not send or store answers. Page generated 2026-08-29. See our editorial standards.